
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
Respiratory signs and symptoms in newborns may reflect a problem that requires treatment or referral. A systems-based approach will help you recognize true respiratory distress and keep evaluation and management on track.






